Interferon-λ3 Exacerbates the Inflammatory Response to Microbial Ligands: Implications for SARS-CoV-2 Pathogenesis

References

• Lazear HM, Nice TJ, Diamond MS. Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity. 2015;43(1):15–28. doi:10.1016/j.immuni.2015.07.001
   PubMed Web of Science ®Google Scholar
• Baldridge MT, Lee S, Brown JJ, et al. Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of IFN-lambda against norovirus and reovirus. J Virol. 2017;91(7). doi:10.1128/JVI.02079-16
   PubMed Web of Science ®Google Scholar
• Odendall C, Voak AA, Kagan JC. Type III IFNs are commonly induced by bacteria-sensing TLRs and reinforce epithelial barriers during infection. J Immunol. 2017;199(9):3270–3279. doi:10.4049/jimmunol.1700250
   PubMed Web of Science ®Google Scholar
• Espinosa V, Dutta O, McElrath C, et al. Type III interferon is a critical regulator of innate antifungal immunity. Sci Immunol. 2017;2(16).
   PubMed Web of Science ®Google Scholar
• Read SA, Wijaya R, Ramezani-Moghadam M, et al. Macrophage coordination of the interferon lambda immune response. Front Immunol. 2019;10:2674.
   PubMed Web of Science ®Google Scholar
• Finotti G, Tamassia N, Cassatella MA. Interferon-lambda s and plasmacytoid dendritic cells: a close relationship. Front Immunol. 2017;8.
   PubMed Web of Science ®Google Scholar
• Santer DM, Minty GES, Golec DP, et al. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells. PLoS Pathog. 2020;16(4).
   PubMed Web of Science ®Google Scholar
• Eslam M, McLeod D, Kelaeng KS, et al. IFN-lambda3, not IFN-lambda4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis. Nat Genet. 2017;49(5):795–800.
   PubMed Web of Science ®Google Scholar
• Eslam M, Hashem AM, Leung R, et al. Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun. 2015;6:6422.
   PubMed Web of Science ®Google Scholar
• Metwally M, Thabet K, Bayoumi A, et al. IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Sci Rep. 2019;9.
   PubMed Web of Science ®Google Scholar
• Witte E, Kokolakis G, Witte K, et al. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med. 2016;94(4):391–400. doi:10.1007/s00109-015-1367-y
   PubMed Web of Science ®Google Scholar
• Zahn S, Rehkamper C, Kummerer BM, et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN lambda) in cutaneous lupus erythematosus. J Invest Dermatol. 2011;131(1):133–140. doi:10.1038/jid.2010.244
   PubMed Web of Science ®Google Scholar
• Goel RR, Wang X, O’Neil LJ, et al. Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus. Proc Natl Acad Sci U S A. 2020;117(10):5409–5419. doi:10.1073/pnas.1916897117
   PubMed Web of Science ®Google Scholar
• Getts DR, Chastain EML, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255(1):197–209. doi:10.1111/imr.12091
   PubMed Web of Science ®Google Scholar
• Chopra P, Gupta S, Dastidar SG, Ray A. Development of cell death-based method for the selectivity screening of caspase-1 inhibitors. Cytotechnology. 2009;60(1–3):77–83. doi:10.1007/s10616-009-9217-9
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. doi:10.1093/bioinformatics/bts635
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–140. doi:10.1093/bioinformatics/btp616
   PubMed Web of Science ®Google Scholar
• Kamburov A, Wierling C, Lehrach H, Herwig R. ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res. 2009;37(suppl_1):D623–D628. doi:10.1093/nar/gkn698
   PubMedGoogle Scholar
• Zambelli F, Pesole G, Pavesi G. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res. 2009;37(WebServer issue):W247–252. doi:10.1093/nar/gkp464
   PubMedGoogle Scholar
• Lieberman NAP, Peddu V, Xie H, et al. In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age. bioRxiv. 2020. doi:10.1101/2020.06.22.165225
   Google Scholar
• R: a language and environment for statistical computing [computer program]. Vienna, Austria: Foundation for Statistical Computing; 2013.
   Google Scholar
• Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773–782. doi:10.1038/s41587-019-0114-2
   PubMed Web of Science ®Google Scholar
• Chiriac MT, Buchen B, Wandersee A, et al. Activation of epithelial signal transducer and activator of transcription 1 by interleukin 28 controls mucosal healing in mice with colitis and is increased in mucosa of patients with inflammatory bowel disease. Gastroenterology. 2017;153(1):123–138e128. doi:10.1053/j.gastro.2017.03.015
   PubMed Web of Science ®Google Scholar
• Chu H, Chan JF, Wang Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71(6):1400–1409. doi:10.1093/cid/ciaa410
   PubMed Web of Science ®Google Scholar
• Alho OP, Karttunen TJ, Karttunen R, Tuokko H, Koskela M, Uhari M. Lymphocyte and mast cell counts are increased in the nasal mucosa in symptomatic natural colds. Clin Exp Immunol. 2003;131(1):138–142. doi:10.1046/j.1365-2249.2003.02037.x
   PubMed Web of Science ®Google Scholar
• Vanders RL, Hsu A, Gibson PG, Murphy VE, Wark PAB. Nasal epithelial cells to assess in vitro immune responses to respiratory virus infection in pregnant women with asthma. Respir Res. 2019;20(1):259. doi:10.1186/s12931-019-1225-5
   PubMed Web of Science ®Google Scholar
• Sungnak W, Huang N, Becavin C, et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. 2020;26(5):681–687. doi:10.1038/s41591-020-0868-6
   PubMed Web of Science ®Google Scholar
• Pott J, Mahlakoiv T, Mordstein M, et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci U S A. 2011;108(19):7944–7949. doi:10.1073/pnas.1100552108
   PubMed Web of Science ®Google Scholar
• Galani IE, Triantafyllia V, Eleminiadou EE, et al. Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity. 2017;46(5):875. doi:10.1016/j.immuni.2017.04.025
   PubMed Web of Science ®Google Scholar
• Gadd VL, Skoien R, Powell EE, et al. The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease. Hepatology. 2014;59(4):1393–1405. doi:10.1002/hep.26937
   PubMed Web of Science ®Google Scholar
• Jones GR, Bain CC, Fenton TM, et al. Dynamics of colon monocyte and macrophage activation during colitis. Front Immunol. 2018;9:9. doi:10.3389/fimmu.2018.02764
   PubMed Web of Science ®Google Scholar
• Read SA, Wijaya R, Ramezani-Moghadam M, et al. Macrophage coordination of the interferon lambda immune response. Front Immunol. 2019;10:10. doi:10.3389/fimmu.2019.02674
   PubMed Web of Science ®Google Scholar
• Friedman SL, Ratziu V, Harrison SA, et al. A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis. Hepatology. 2017.
   Web of Science ®Google Scholar
• Suzaki Y, Hamada K, Nomi T, et al. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur Respir J. 2008;31(4):783–789. doi:10.1183/09031936.00111507
   PubMed Web of Science ®Google Scholar
• Mencarelli A, Cipriani S, Francisci D, et al. Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis. Sci Rep. 2016;6.
   PubMed Web of Science ®Google Scholar
• Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531–543. doi:10.1038/s41575-019-0172-4
   PubMed Web of Science ®Google Scholar
• Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi:10.1016/j.jinf.2020.05.046
   PubMed Web of Science ®Google Scholar
• Odendall C, Dixit E, Stavru F, et al. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat Immunol. 2014;15(8):717–726. doi:10.1038/ni.2915
   PubMed Web of Science ®Google Scholar
• Pervolaraki K, Stanifer ML, Munchau S, et al. Type I and type III interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut. Front Immunol. 2017;8:459. doi:10.3389/fimmu.2017.00459
   PubMed Web of Science ®Google Scholar
• Yang CH, Murti A, Pfeffer SR, Basu L, Kim JG, Pfeffer LM. IFNalpha/beta promotes cell survival by activating NF-kappa B. Proc Natl Acad Sci U S A. 2000;97(25):13631–13636.
   PubMed Web of Science ®Google Scholar
• Maher SG, Sheikh F, Scarzello AJ, et al. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity. Cancer Biol Ther. 2008;7(7):1109–1115.
   PubMed Web of Science ®Google Scholar
• Veeranki S, Duan X, Panchanathan R, Liu H, Choubey D. IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PLoS One. 2011;6(10):e27040.
   PubMed Web of Science ®Google Scholar
• Cohen TS, Prince AS. Bacterial pathogens activate a common inflammatory pathway through IFNlambda regulation of PDCD4. PLoS Pathog. 2013;9(10):e1003682.
   PubMed Web of Science ®Google Scholar
• Kopitar-Jerala N. The role of interferons in inflammation and inflammasome activation. Front Immunol. 2017;8:873.
   PubMed Web of Science ®Google Scholar
• Rajan JV, Warren SE, Miao EA, Aderem A. Activation of the NLRP3 inflammasome by intracellular poly I:C. FEBS Lett. 2010;584(22):4627–4632.
   PubMed Web of Science ®Google Scholar
• Vishnubalaji R, Shaath H, Alajez NM. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes (Basel). 2020;11(7).
   PubMed Web of Science ®Google Scholar
• Lee JS, Park S, Jeong HW, et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5(49).
   Web of Science ®Google Scholar
• Sa Ribero M, Jouvenet N, Dreux M, Nisole S. Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog. 2020;16(7):e1008737.
   PubMed Web of Science ®Google Scholar
• Yang D, Hou Y, Chai Y, et al. Attenuated interferon and proinflammatory response in SARS-CoV-2–infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation. J Infect Dis. 2020;222(5).
   Web of Science ®Google Scholar
• Bost P, Giladi A, Liu Y, et al. Host-viral infection maps reveal signatures of severe COVID-19 patients. Cell. 2020;181(7):1475–1488e1412.
   PubMed Web of Science ®Google Scholar
• Xu G, Qi F, Li H, et al. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov. 2020;6:73.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Blot M, Jacquier M, Glele LSA, et al. CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS. Crit Care. 2020;24(1).
   PubMed Web of Science ®Google Scholar
• Zuo Y, Yalavarthi S, Shi H, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11).
   Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020;18(1):206.
   PubMed Web of Science ®Google Scholar
• Java A, Apicelli AJ, Liszewski MK, et al. The complement system in COVID-19: friend and foe? JCI Insight. 2020.
   PubMed Web of Science ®Google Scholar